Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$269.37 - $365.04 $2.43 Million - $3.29 Million
9,015 Added 127.78%
16,070 $5.19 Million
Q3 2023

Nov 15, 2023

BUY
$350.25 - $422.63 $2.47 Million - $2.98 Million
7,055 New
7,055 $2.53 Million
Q1 2023

May 15, 2023

SELL
$418.69 - $503.0 $650,644 - $781,662
-1,554 Reduced 10.15%
13,759 $6.59 Million
Q4 2022

Feb 14, 2023

BUY
$351.71 - $456.01 $960,168 - $1.24 Million
2,730 Added 21.7%
15,313 $6.44 Million
Q3 2022

Nov 14, 2022

BUY
$412.59 - $563.26 $4.8 Million - $6.56 Million
11,645 Added 1241.47%
12,583 $5.25 Million
Q2 2022

Aug 15, 2022

SELL
$463.67 - $597.16 $2.46 Million - $3.16 Million
-5,298 Reduced 84.96%
938 $464,000
Q1 2022

May 16, 2022

SELL
$524.57 - $735.42 $59,276 - $83,102
-113 Reduced 1.78%
6,236 $3.51 Million
Q4 2021

Feb 14, 2022

BUY
$708.84 - $794.68 $4.12 Million - $4.62 Million
5,812 Added 1082.31%
6,349 $4.8 Million
Q3 2021

Nov 15, 2021

SELL
$657.71 - $825.77 $4.14 Million - $5.19 Million
-6,291 Reduced 92.14%
537 $401,000
Q2 2021

Aug 16, 2021

BUY
$576.64 - $649.04 $202,400 - $227,813
351 Added 5.42%
6,828 $4.4 Million
Q1 2021

May 17, 2021

BUY
$547.01 - $662.35 $3.32 Million - $4.02 Million
6,071 Added 1495.32%
6,477 $3.7 Million
Q4 2020

Feb 16, 2021

SELL
$510.68 - $643.45 $2.57 Million - $3.24 Million
-5,033 Reduced 92.54%
406 $237,000
Q3 2020

Nov 16, 2020

BUY
$454.43 - $535.6 $1.18 Million - $1.39 Million
2,586 Added 90.64%
5,439 $2.8 Million
Q2 2020

Aug 14, 2020

BUY
$334.87 - $493.06 $955,384 - $1.41 Million
2,853 New
2,853 $1.29 Million
Q4 2018

Feb 14, 2019

SELL
$220.1 - $309.0 $421,931 - $592,353
-1,917 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$289.28 - $326.15 $554,549 - $625,229
1,917 New
1,917 $600,000
Q1 2018

May 15, 2018

SELL
$233.97 - $274.11 $603,642 - $707,203
-2,580 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$216.94 - $271.3 $559,705 - $699,954
2,580
2,580 $616,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.38B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.